Search Results - "Vick, Andrew"

Refine Results
  1. 1

    Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein by Glaesner, Wolfgang, Mark Vick, Andrew, Millican, Rohn, Ellis, Bernice, Tschang, Sheng-Hung, Tian, Yu, Bokvist, Krister, Brenner, Martin, Koester, Anja, Porksen, Niels, Etgen, Garret, Bumol, Tom

    Published in Diabetes/metabolism research and reviews (01-05-2010)
    “…Background Glucagon‐like peptide‐1 (GLP‐1) receptor agonists are novel agents for type 2 diabetes treatment, offering glucose‐dependent insulinotropic effects,…”
    Get full text
    Journal Article
  2. 2

    Non-destructive imaging of buried electronic interfaces using a decelerated scanning electron beam by Hirohata, Atsufumi, Yamamoto, Yasuaki, Murphy, Benedict A., Vick, Andrew J.

    Published in Nature communications (02-09-2016)
    “…Recent progress in nanotechnology enables the production of atomically abrupt interfaces in multilayered junctions, allowing for an increase in the number of…”
    Get full text
    Journal Article
  3. 3

    Characterization of All Graphs with a Failed Skew Zero Forcing Number of 1 by Johnson, Aidan, Vick, Andrew E., Narayan, Darren A.

    Published in Mathematics (Basel) (01-12-2022)
    “…Given a graph G, the zero forcing number of G, Z(G), is the minimum cardinality of any set S of vertices of which repeated applications of the forcing rule…”
    Get full text
    Journal Article
  4. 4

    Highly Efficient Spin-Current Operation in a Cu Nano-Ring by Murphy, Benedict A., Vick, Andrew J., Samiepour, Marjan, Hirohata, Atsufumi

    Published in Scientific reports (21-11-2016)
    “…An all-metal lateral spin-valve structure has been fabricated with a medial Copper nano-ring to split the diffusive spin-current path. We have demonstrated…”
    Get full text
    Journal Article
  5. 5

    Increased bioavailability of celecoxib under fed versus fasted conditions is determined by postprandial bile secretion as demonstrated in a dynamic gastrointestinal model by Lyng, Eric, Havenaar, Robert, Shastri, Prathap, Hetsco, Lucy, Vick, Andrew, Sagartz, John

    Published in Drug development and industrial pharmacy (01-08-2016)
    “…The objective of this study was to utilize physiologically relevant dynamic dissolution testing with the TNO intestinal model (TIM-1) in vitro gastrointestinal…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Growth and Characterisation of Antiferromagnetic Ni2MnAl Heusler Alloy Films by Huminiuc, Teodor, Whear, Oliver, Vick, Andrew J., Lloyd, David C., Vallejo-Fernandez, Gonzalo, O’Grady, Kevin, Hirohata, Atsufumi

    Published in Magnetochemistry (01-09-2021)
    “…Recent rapid advancement in antiferromagnetic spintronics paves a new path for efficient computing with THz operation. To date, major studies have been…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase by Vaughn, Daniel E, Yocum, Richard C, Muchmore, Douglas B, Sugarman, Barry J, Vick, Andrew M, Bilinsky, Igor P, Frost, Gregory I

    Published in Diabetes technology & therapeutics (01-06-2009)
    “…This phase 1 study investigated the pharmacokinetics (PK) and glucodynamics of insulin lispro (Humalog; Eli Lilly and Co., Indianapolis, IN) or regular human…”
    Get more information
    Journal Article
  12. 12

    pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity by KOHN, Wayne D, MICANOUIC, Radmila, MAYER, John P, DIMARCHI, Richard D, MYERS, Sharon L, VICK, Andrew M, KAHL, Steuen D, LIANSHAN ZHANG, STRIFLER, Beth A, SHUN LI, JING SHANG, BEALS, John M

    Published in Peptides (New York, N.Y. : 1980) (01-04-2007)
    “…A long-acting (basal) insulin capable of delivering flat, sustained, reproducible glycemic control with once daily administration represents an improvement in…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics and hepatic extraction of recombinant human parathyroid hormone, hPTH (1-34), in rat, dog, and monkey by Jones, Karen O, Owusu-Ababio, Godfried, Vick, Andrew M, Khan, M Amin

    Published in Journal of pharmaceutical sciences (01-11-2006)
    “…The pharmacokinetics (PK) and hepatic extraction (E(H)) of human PTH (1-34), hPTH (1-34), were characterized in rat, dog, and monkey, following intraportal…”
    Get more information
    Journal Article
  14. 14

    Methyltestosterone pharmacolinetics and oral bioavailability in rainbow trout ( Oncorhynchus mykiss) by Vick, Andrew M, Hayton, William L

    Published in Aquatic toxicology (01-05-2001)
    “…14C-methyltestosterone pharmacokinetics after intraarterial (2 and 20 mg/kg) and oral (30 mg/kg) administration were investigated in rainbow trout at 15°C…”
    Get full text
    Journal Article Conference Proceeding
  15. 15
  16. 16

    AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients by Martin, Kevin J, Pickthorn, Karen, Huang, Saling, Block, Geoffrey A, Vick, Andrew, Mount, Peter F, Power, David A, Bell, Gregory

    Published in Kidney international (01-01-2014)
    “…AMG 416 (velcalcetide), a novel peptide agonist of the calcium-sensing receptor, lowers plasma parathyroid hormone in preclinical uremic animal models and in…”
    Get more information
    Journal Article
  17. 17

    Biological Matrix Supply Chain Shortages: More Matrices Are Now Rare—the Case for Surrogate Matrices by Dubiel, Evan A., Myler, Heather, Arnold, Mark E., Bennett, Patrick, Gatz, Jeff, Groeber, Elizabeth, Gupta, Seema, Kane, Cheikh, Li, Fumin, Mylott, William, Noah, Courtney, O’Dell, Mark, Tewalt, Eric, Warrino, Dominic, Vick, Andrew

    Published in The AAPS journal (14-03-2022)
    “…The COVID-19 pandemic has strained the biological matrix supply chain. An upsurge in demand driven by numerous COVID-19 therapeutic and vaccine development…”
    Get full text
    Journal Article
  18. 18

    Implementation of dose superimposition to introduce multiple doses for a mathematical absorption model (transit compartment model) by Shen, Jun, Boeckmann, Alison, Vick, Andrew

    “…A mathematical absorption model (e.g. transit compartment model) is useful to describe complex absorption process. However, in such a model, an assumption has…”
    Get full text
    Journal Article
  19. 19

    Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects by Martin, Kevin J, Bell, Gregory, Pickthorn, Karen, Huang, Saling, Vick, Andrew, Hodsman, Peter, Peacock, Munro

    Published in Nephrology, dialysis, transplantation (01-02-2014)
    “…Velcalcetide, also known as AMG 416, is a novel, long-acting selective peptide agonist of the calcium sensing receptor. It is being developed as an intravenous…”
    Get full text
    Journal Article
  20. 20

    A pharmacokinetic/pharmacodynamic model for AMG 416, a novel calcimimetic peptide, following a single intravenous dose in healthy subjects by Shen, Jun, Xiao, Jim, Pickthorn, Karen, Huang, Saling, Bell, Gregory, Vick, Andrew, Chen, Ping

    Published in Journal of clinical pharmacology (01-10-2014)
    “…AMG 416 is a novel peptide agonist of the calcium‐sensing receptor. In support of the clinical development program, a pharmacokinetic (PK)/pharmacodynamic (PD)…”
    Get full text
    Journal Article